Z
Zara Izadi
Researcher at University of California, San Francisco
Publications - 41
Citations - 1807
Zara Izadi is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 9, co-authored 25 publications receiving 862 citations. Previous affiliations of Zara Izadi include University of California.
Papers
More filters
Journal ArticleDOI
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.
Milena A. Gianfrancesco,Kimme L. Hyrich,Sarah Al-Adely,Loreto Carmona,Maria I. Danila,Maria I. Danila,Laure Gossec,Zara Izadi,Lindsay Jacobsohn,Patricia P. Katz,Saskia Lawson-Tovey,Elsa F Mateus,Stephanie Rush,Gabriela Schmajuk,Julia F. Simard,Anja Strangfeld,Laura Trupin,Katherine D Wysham,Suleman Bhana,Wendy Costello,Rebecca Grainger,Jonathan S. Hausmann,Jonathan S. Hausmann,Jean W. Liew,Emily Sirotich,Paul Sufka,Zachary S. Wallace,Jinoos Yazdany,Pedro Machado,Philip Robinson,Philip Robinson +30 more
TL;DR: It is found that glucocorticoid exposure of ≥10 mg/day is associated with a higher odds of hospitalisation and anti-TNF with a decreased odds ofospitalisation in patients with rheumatic disease.
Journal ArticleDOI
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry.
Anja Strangfeld,Martin Schäfer,Milena A. Gianfrancesco,Saskia Lawson-Tovey,Jean W. Liew,Lotta Ljung,Elsa F Mateus,Christophe Richez,Maria José Santos,Gabriela Schmajuk,Carlo Alberto Scirè,Emily Sirotich,Jeffrey A. Sparks,Paul Sufka,Thierry Thomas,Laura Trupin,Zachary S. Wallace,Sarah Al-Adely,Javier Bachiller-Corral,Suleman Bhana,Patrice Cacoub,Loreto Carmona,Ruth Costello,Wendy Costello,Laure Gossec,Rebecca Grainger,Eric Hachulla,Rebecca Hasseli,Jonathan S. Hausmann,Kimme L. Hyrich,Zara Izadi,Lindsay Jacobsohn,Patricia P. Katz,Lianne Kearsley-Fleet,Philip Robinson,Philip Robinson,Jinoos Yazdany,Pedro Machado +37 more
TL;DR: In this paper, the authors determined factors associated with COVID-19-related death in people with rheumatic diseases, including age, sex, smoking status, comorbidities, diagnosis, disease activity and medications.
Journal ArticleDOI
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry
Jeffrey A. Sparks,Zachary S. Wallace,Andrea M Seet,Milena A. Gianfrancesco,Zara Izadi,Kimme L. Hyrich,Anja Strangfeld,Laure Gossec,Loreto Carmona,Elsa F Mateus,Saskia Lawson-Tovey,Laura Trupin,Stephanie Rush,Patricia P. Katz,Gabriela Schmajuk,Lindsay Jacobsohn,Leanna Wise,Emily L Gilbert,Alí Duarte-García,Maria O Valenzuela-Almada,Guillermo J. Pons-Estel,Carolina A. Isnardi,Guillermo A. Berbotto,Tiffany Y.T. Hsu,Kristin M. D’Silva,Naomi J Patel,Lianne Kearsley-Fleet,Lianne Kearsley-Fleet,Martin Schäfer,Sandra Lúcia Euzébio Ribeiro,Samar Al Emadi,Liselotte Tidblad,Carlo Alberto Scirè,Bernd Raffeiner,Thierry Thomas,René Marc Flipo,Jérôme Avouac,Raphaèle Seror,Miguel Bernardes,Maria Margarida Cunha,Rebecca Hasseli,Hendrik Schulze-Koops,Ulf Müller-Ladner,Christof Specker,Viviane Angelina de Souza,Licia Maria Henrique da Mota,Ana Paula Monteiro Gomides,Philippe Dieudé,Elena Nikiphorou,Elena Nikiphorou,Vanessa L. Kronzer,Namrata Singh,Manuel F. Ugarte-Gil,Beth I Wallace,Akpabio Akpabio,Ranjeny Thomas,Suleman Bhana,Wendy Costello,Rebecca Grainger,Jonathan S. Hausmann,Jean W. Liew,Emily Sirotich,Paul Sufka,Philip Robinson,Philip Robinson,Pedro Machado,Jinoos Yazdany +66 more
TL;DR: In this article, the authors investigated baseline use of biologic or targeted synthetic (b/ts) disease-modifying antirheumatic drugs (DMARDs) and COVID-19 outcomes in rheumatoid arthritis (RA).
Journal ArticleDOI
Association of Race and Ethnicity With COVID-19 Outcomes in Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance Physician Registry
Milena A. Gianfrancesco,Liza A. Leykina,Zara Izadi,Tiffany Taylor,Jeffrey A. Sparks,Carly Harrison,Laura Trupin,Stephanie Rush,Gabriela Schmajuk,Patricia P. Katz,Lindsay Jacobsohn,Tiffany Y.T. Hsu,Kristin M. D’Silva,Naomi Serling-Boyd,Rachel Wallwork,Derrick J. Todd,Suleman Bhana,Wendy Costello,Rebecca Grainger,Jonathan S. Hausmann,Jean W. Liew,Emily Sirotich,Paul Sufka,Zachary S. Wallace,Pedro Machado,Philip Robinson,Jinoos Yazdany +26 more
TL;DR: Racial/ethnic minorities experience more severe outcomes of coronavirus disease 2019 (COVID‐19) in the general US population than the general population and race/ethnicity is associated with hospitalization, ventilation status, and mortality in people with rheumatic disease.
Journal ArticleDOI
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance
Manuel F. Ugarte-Gil,Graciela S. Alarcón,Zara Izadi,Alí Duarte-García,Cristina Reátegui-Sokolova,Ann E. Clarke,Leanna Wise,Guillermo J. Pons-Estel,Maria José Santos,Sasha Bernatsky,Sandra Lúcia Euzébio Ribeiro,Samar Al Emadi,Jeffrey A. Sparks,Tiffany Y.T. Hsu,N. Patel,Emily L. Gilbert,Maria O Valenzuela-Almada,Andreas Jönsen,Gianpiero Landolfi,Micaela Fredi,Tiphaine Goulenok,Mathilde Devaux,Xavier Mariette,Viviane Queyrel,Vasco C. Romão,G. Sequeira,Rebecca Hasseli,Bimba F. Hoyer,Reinhard E. Voll,Christof Specker,R. Báez,Vanessa Castro Coello,Hernán Maldonado Ficco,E. Reis Neto,Gilda Aparecida Ferreira,Odirlei André Monticielo,Emily Sirotich,Jean W. Liew,Jonathan S. Hausmann,Paul Sufka,Rebecca Grainger,Suleman Bhana,Wendy Costello,Zachary S. Wallace,Lindsay Jacobsohn,Tiffany Taylor,Clairissa Ja,Anja Strangfeld,Elsa F Mateus,Kimme L. Hyrich,Loreto Carmona,Saskia Lawson-Tovey,Lianne Kearsley-Fleet,Martin Schäfer,Pedro Machado,Philip Robinson,Milena A. Gianfrancesco,Jinoos Yazdany +57 more
TL;DR: More severe COVID-19 outcomes in individuals with SLE are largely driven by demographic factors, comorbidities and untreated or active SLE.